Published in Acta Clin Belg on January 01, 1977
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood (1995) 5.34
Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood (1995) 2.59
Inadequate detection of accessory spleens and splenosis with laparoscopic splenectomy. A shortcoming of the laparoscopic approach in hematologic diseases. Surg Endosc (1998) 2.32
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol (2000) 2.21
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant (2003) 2.19
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet (1996) 2.06
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Ann Hematol (2007) 2.05
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon. Acta Clin Belg (1995) 1.95
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med (1995) 1.94
Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70
Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b. Nephrol Dial Transplant (1995) 1.59
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant (1998) 1.57
Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents (2007) 1.57
Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Br J Haematol (1990) 1.56
Vertebral compression fractures in multiple myeloma. Part I. Distribution and appearance at MR imaging. Radiology (1997) 1.47
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br J Haematol (1998) 1.43
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine. Br J Haematol (2001) 1.42
Differences in the chromosomal profile of AML-M0 versus AML-M1: response. Blood (1996) 1.42
Guidelines for the transfusion of red cells. Acta Clin Belg (2009) 1.41
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Splenic lymphoma presenting as necrotizing glomerulonephritis. Clin Nephrol (1998) 1.39
Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood (1992) 1.39
The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation. Haematologica (1991) 1.38
Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood (1999) 1.37
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol (1996) 1.27
Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features. Haematologica (1997) 1.23
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol (1993) 1.18
Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology (1997) 1.16
Laparoscopic splenectomy in adults and children: experience with 31 patients. Surgery (1996) 1.15
Bone marrow transplantation in sickle cell anaemia. Arch Dis Child (1991) 1.14
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13
Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol (1998) 1.12
Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology (1998) 1.11
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. Leukemia (2007) 1.10
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Ann Oncol (2009) 1.08
In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. J Nucl Med (1988) 1.06
Detection of skeletal involvement in Hodgkin's disease: a comparison of radiography, bone scanning and bone marrow biopsy in 38 patients. Cancer (1975) 1.06
A new hematologic syndrome with a distinct karyotype: the 5 q--chromosome. Blood (1975) 1.05
Magnetic resonance imaging of the bone marrow in hematological malignancies. Eur Radiol (1998) 1.03
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol (2000) 0.99
Remission of severe cold agglutinin disease after Rituximab therapy. Leukemia (2001) 0.99
Long-term effects of localized spinal radiation therapy on vertebral fractures and focal lesions appearance in patients with multiple myeloma. Br J Haematol (1997) 0.99
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis (2007) 0.97
Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol (1999) 0.95
High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Ann Hematol (1994) 0.95
Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Cancer (1996) 0.94
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia. Leukemia (2010) 0.91
Meningococcal purpura: report of 19 patients treated with heparin. J Pediatr (1973) 0.89
High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies. Ann Hematol (2004) 0.89
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1999) 0.89
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia (1994) 0.89
Indium-111 leucocyte scanning in the evaluation of painful hip arthroplasty. Acta Orthop Scand (1983) 0.88
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy. Bone Marrow Transplant (2011) 0.88
Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology (1996) 0.87
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol (2011) 0.87
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLL. Leukemia (2005) 0.87
Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br J Haematol (1996) 0.87
Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol (1991) 0.87
Bone marrow transplantation in patients with multiple myeloma: prognostic significance of MR imaging. AJR Am J Roentgenol (2001) 0.86
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer (2000) 0.86
Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. Ann Hematol (2004) 0.85
Quantitative organ-uptake measurement with a gamma camera. Eur J Nucl Med (1979) 0.84
Bronchoesophageal fistula caused by pulmonary aspergillosis. Eur J Respir Dis (1985) 0.84
Bilateral granulomatous panuveitis as initial presentation of diffuse systemic T cell lymphoma. Ophthalmologica (1999) 0.83
Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma. Oncology (1993) 0.83
Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Br J Surg (1994) 0.83
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents. Leukemia (2013) 0.83
Dicentric (1;15) in myeloid disorders. Cancer Genet Cytogenet (1996) 0.82
Effects of suloctidil on platelet survival time following cardiac valve replacement. Thromb Haemost (1981) 0.81
Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia (2007) 0.81
Guidelines for the transfusion of platelets. Acta Clin Belg (2007) 0.81
Guidelines for the use of fresh frozen plasma. Acta Clin Belg (2009) 0.81
Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology (1997) 0.81
2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. N Engl J Med (1993) 0.80
A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells. Br J Haematol (2000) 0.80
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.). Thromb Haemost (1982) 0.80
Propylene glycol-induced heparin resistance during nitroglycerin infusion. Am Heart J (1985) 0.80
Indium-111-pentetreotide uptake in endocrine tumors and lymphoma. J Nucl Med (1996) 0.80
Assessment of bone marrow blood flow using positron emission tomography: no relationship with bone marrow cellularity. Br J Haematol (1987) 0.79
2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes. Leukemia (2002) 0.79
Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage. Ann Hematol (2001) 0.79
Acute lymphoblastic leukemia in the elderly. Eur J Haematol (1990) 0.79
Comparative effects of dextrans, gelatin and stable plasma protein solution (SPPS) on the experimental disseminated intravascular coagulation (DIC). Vox Sang (1974) 0.79
New evidences for a regulation of deoxycytidine kinase activity by reversible phosphorylation. Nucleosides Nucleotides Nucleic Acids (2004) 0.79
Allogeneic bone marrow transplantation for AL amyloidosis. Bone Marrow Transplant (1997) 0.79
Long-term favourable outcome of portal hypertension complicating primary systemic amyloidosis. Liver (1995) 0.79
[Emergency surgery for massive hemorrhage from ruptured esophageal varices in the cirrhotic patient (author's transl)]. Acta Gastroenterol Belg (1974) 0.79